Belviq (Lorcaserin) for Obesity

Overview
Belviq is a prescription drug approved by the Food and Drug Administration (FDA) for chronic weight management in conjunction with a reduced-calorie diet and exercise. Belviq may be prescribed for adults with a body mass index (BMI) of 30 or greater. Adults with a BMI of 27 or greater may be considered candidates for Belviq if they have at least one weight-related medical condition. Belviq is also referred to by its drug name, Lorcaserin.

Belviq is an appetite suppressant. It is believed that Belviq works by acting on your brain to make you feel full.

How do I take it?
Prescribing information states that Belviq should be taken twice daily.

Belviq comes in tablet form.

Side effects
The FDA-approved label for Belviq lists common side effects including headache, dizziness, dry mouth, nausea, and constipation.

Rare but serious side effects listed for Belviq include serotonin syndrome, valvular heart disease, psychiatric disorders, suicidal thoughts, hypoglycemia, and priapism in men.

For more details about this treatment, visit:
Belviq – Eisai
http://www.belviq.com/